The Oncology Institute Boosts Medicare Savings to $1.8M in CMS EOM Period 3
Event summary
- The Oncology Institute (TOI) achieved $1.8M in Medicare savings during CMS EOM Performance Period 3, up from $1.1M in Period 2.
- Savings per patient episode increased from $3,500 to $6,400.
- TOI earned the maximum score on avoidable emergency department visits and hospital admissions for the second consecutive period.
- Results driven by High-Value Cancer Care program, including proactive care navigation and 24/7 symptom management.
The big picture
TOI's performance underscores the growing emphasis on value-based care in oncology, where cost efficiency and quality outcomes are increasingly tied to reimbursement models. The company's ability to deliver substantial Medicare savings while maintaining high-quality care reinforces the viability of community-based oncology in the shifting healthcare landscape. With over 100 clinic locations across five states, TOI's model could set a benchmark for scalable, value-driven cancer care.
What we're watching
- Scalability
- Whether TOI can sustain this pace of savings growth in subsequent EOM periods.
- Regulatory Dynamics
- How CMS's continued focus on value-based models will impact TOI's strategic positioning.
- Competitive Differentiation
- The pace at which other oncology practices adopt similar value-based care models.
Related topics